Exelixis, Inc. reported STELLAR-303 trial results for zanzalintinib plus atezolizumab vs. regorafenib in mCRC. Learn more ...

A unique long-term study, in which biological samples were collected from the same population of blue tits over a 30-year period, shows that rising spring temperatures have doubled the incidence of ...

Introduction A substantial number of patients with major depressive disorder experience non-remission despite treatment with psychotherapy and several antidepressant drugs. This has increased the ...